Researchers have conducted a quantitative keyword analysis of 30 million articles in the life sciences over a nearly fifty-year period (1970-2017) and found that 75% of total emerging keywords, at 1-year prior to becoming identified as emerging, co-appeared with other emerging keywords in the same article.
Read moreScientists have made an important discovery in understanding the role a particular protein plays to impair memory in Alzheimer's disease, which could lead to more effective treatment in future.
Read moreIn the years since her lab discovered that exposing Alzheimer's disease model mice to light flickering at the frequency of a key brain rhythm could stem the disorder's pathology, a neuroscientist and her team have been working to understand what the phenomenon may mean both for fighting the disease and understanding of how the brain works.
Read moreMedical researchers have demonstrated how estrogen — a natural hormone produced in the body — can be polymerized into a slow-releasing biomaterial and applied to nervous system cells to protect those cells and even promote regeneration.
Read moreA new study indicates that people with dementia — whose parents also had dementia — develop symptoms an average of six years earlier than their parents.
Read moreNeuroscientists say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.
Read moreOlder people who experienced more hospitalizations and also had more Alzheimer's pathology in their brain experienced the fastest rates of cognitive decline, according to a new study.
Read moreThree-hundred researchers have identified 48 common genetic variants that are associated with the size of the brainstem and other subcortical structures deep within the brain. This is the first step toward understanding how to devise treatments for disorders affecting these structures.
Read moreResearchers used a grip-force test to analyze sensorimotor function in people with the FMR1 premutation, with the aim of determining FXTAS risk and severity.
Read moreA team of researchers has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.
Read more